Carter's (CRI)
(Delayed Data from NYSE)
$61.20 USD
+0.32 (0.53%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $61.17 -0.03 (-0.05%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$61.20 USD
+0.32 (0.53%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $61.17 -0.03 (-0.05%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth D Momentum A VGM
Zacks News
CRI vs. NKE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
Zacks.com featured highlights include Carter, Expro Group Holdings, and Nielsen
by Zacks Equity Research
Carter's, Expro Group Holdings, and Nielsen are part of the Screen of the Week Article.
3 Top Stocks to Invest In for Superb Earnings Acceleration
by Tirthankar Chakraborty
Invest in stocks like Carter's (CRI), Expro Group Holdings (XPRO) and Nielsen (NLSN) for now because of solid earnings acceleration.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CRI or NKE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
Carter's (CRI) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights include Carter's, AutoNation, Teck Resources, TotalEnergies and Marathon Petroleum
by Zacks Equity Research
Carter's, AutoNation, Teck Resources, TotalEnergies and Marathon Petroleum have been highlighted in this Screen of the week article.
5 PEG-Based GARP Stocks for a Winning Portfolio
by Urmimala Biswas
Here we screen five GARP stocks, CRI, AN, TECK, TTE, and MPC based on discounted PEG
The Zacks Analyst Blog Highlights Builders FirstSource, Carter's and Target
by Zacks Equity Research
Builders FirstSource, Carter's and Target have been highlighted in this Analyst Blog.
Zacks.com featured highlights include Carters, Fluor, Micron Technology, Callon Petroleum and Iron Mountain
by Zacks Equity Research
Carters, Fluor, Micron Technology, Callon Petroleum and Iron Mountain have been highlighted in this Screen of the Week article.
Capitalize On a Rebounding Market With 3 Highly Ranked Retail Stocks
by Derek Lewis
Riding on the tails of last Wednesday's meeting with the Fed, the major indices turned in their best weekly performances since last November and provided investors with a much-needed relief rally.
Invest in These 5 Stocks With Upgraded Broker Ratings
by Swayta Shah
One must follow rating upgrades by brokers as they have a deeper understanding of the stocks. So, we choose Carter's (CRI), Fluor (FLR), Micron (MU), Callon Petroleum (CPE) & Iron Mountain (IRM) as these witness ratings upgrades.
CRI vs. NKE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
Zacks.com featured highlights include Carter's, Target Hospitality, iQIYI, The Buckle, and Corbus Pharmaceuticals
by Zacks Equity Research
Carter's, Target Hospitality, iQIYI, The Buckle, and Corbus Pharmaceuticals are part of today's Screen of the Week blog.
Here's Why Carter's (CRI) is Marching Ahead of Its Industry
by Zacks Equity Research
Despite supply-chain woes, Carter's (CRI) seems poised for long-term growth on the back of solid demand, online strength and several growth efforts. Its upbeat 2022 view raises optimism.
CRI or NKE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
Carter's (CRI) Q4 Earnings & Sales Beat on Solid Holiday Season
by Zacks Equity Research
Carter's (CRI) Q4 results gain from robust sales growth, enhanced price realization and robust holiday season. However, supply-chain woes and higher freight remain concerning.
Carter's (CRI) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Carter's (CRI) delivered earnings and revenue surprises of 13.24% and 3.66%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Carter's (CRI) This Earnings Season?
by Zacks Equity Research
Carter's (CRI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Steven Madden (SHOO) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Steven Madden (SHOO) delivered earnings and revenue surprises of 19.18% and 9.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Solid Demand & Online Growth to Aid Carter's (CRI) Q4 Earnings
by Zacks Equity Research
Carter's (CRI) Q4 results are likely to reflect gains from solid demand and sturdy e-commerce business. Higher freight costs and supply-chain issues are likely to have acted as deterrents.
Carter's (CRI) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Carter's (CRI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Crocs (CROX) is Placed Just Ahead of Q4 Earnings
by Zacks Equity Research
Crocs (CROX) Q4 results are expected to reflect benefits of strong demand for its brands, product innovation and digital growth. Supply-chain disruptions and global inflation are likely to have hurt.
Skechers (SKX) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Skechers (SKX) delivered earnings and revenue surprises of 30.30% and 6.97%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Why Carter's (CRI) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Carter's (CRI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.